CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.88B, above the global median of $1.18B
- PositionProfit margin is 54.3%, higher than 95% of its Medical Instruments & Supplies peers (median 8.3%)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
1.88BUSDvs all stocks (USD)
Trailing P/E
38.58xvs Medical Instruments & Supplies peers
Revenue (TTM)
106.69MUSDvs all stocks (USD)
Profit Margin
54.35%vs Medical Instruments & Supplies peers
Beta
1.92xvs all stocks
52-Week Change
56.97%vs all stocks
Market Capitalization
1.88BUSDvs all stocks (USD)
Enterprise Value
1.82BUSDvs all stocks (USD)
Trailing P/E
38.58xvs Medical Instruments & Supplies peers
Forward P/E
116.91xvs Medical Instruments & Supplies peers
PEG Ratio
-0.1019xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
17.69xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
4.49xvs Medical Instruments & Supplies peers
Enterprise to Revenue
17.06xvs Medical Instruments & Supplies peers
Gross Margin
64.24%vs Medical Instruments & Supplies peers
Profit Margin
54.35%vs Medical Instruments & Supplies peers
Operating Margin
5.96%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.26%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
12.83%vs Medical Instruments & Supplies peers
Revenue (TTM)
106.69MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.21USDUpdated Sep 27, 2026Quarterly Revenue Growth
21.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
67.87MUSDvs all stocks (USD)
EBITDA (TTM)
6.41MUSDvs all stocks (USD)
Net Income (TTM)
49.21MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.98%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
16.88MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
4.66MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
96.21MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
34.10MUSDFY2025 · Dec 31, 2025Gross Profit
62.12MUSDFY2025 · Dec 31, 2025Operating Income
-16.60MUSDvs all stocks (USD)
Pre-tax Income
-12.08MUSDFY2025 · Dec 31, 2025Income Tax Expense
49.00KUSDFY2025 · Dec 31, 2025Net Income
-4.59MUSDFY2025 · Dec 31, 2025EBIT
-16.60MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-11.91MUSDFY2025 · Dec 31, 2025Research & Development
23.09MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
55.37MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0900USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.1000USDFY2025 · Dec 31, 2025Basic Shares Outstanding
47.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
47.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-4.59MUSDFY2025 · Dec 31, 2025Operating Cash Flow
37.73MUSDFY2025 · Dec 31, 2025Free Cash Flow
28.25MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
33.04MUSDFY2025 · Dec 31, 2025Interest Paid
762.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-4.59MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
4.69MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
65.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
22.99MUSDFY2025 · Dec 31, 2025Other Non-cash Items
17.40MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
264.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.09MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-999.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-9.48MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-10.22MUSDFY2025 · Dec 31, 2025Net Acquisitions
23.52MUSDFY2025 · Dec 31, 2025Purchase of Investments
-116.06MUSDFY2025 · Dec 31, 2025Sale of Investments
41.59MUSDFY2025 · Dec 31, 2025Other Investing Activity
-886.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-61.32MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-10.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-942.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-10.94MUSDFY2025 · Dec 31, 2025Shares Outstanding
48.89MSharesUpdated Sep 27, 2026Float Shares
42.84MSharesUpdated Sep 27, 2026Shares Short
3.93MSharesUpdated Sep 27, 2026Short Ratio
5.71daysvs all stocks
Short % of Shares Outstanding
12.56%vs all stocks
% Held by Insiders
2.62%vs all stocks
% Held by Institutions
100.18%vs all stocks
Total Cash (MRQ)
82.42MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.69USDUpdated Sep 27, 2026Total Debt (MRQ)
15.74MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0375xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.69xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
8.59USDUpdated Sep 27, 2026Total Assets
405.88MUSDvs all stocks (USD)
Total Current Assets
136.56MUSDFY2025 · Dec 31, 2025Total Liabilities
34.00MUSDFY2025 · Dec 31, 2025Total Non-current Assets
269.32MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
11.02MUSDFY2025 · Dec 31, 2025Total Current Liabilities
22.98MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
33.04MUSDFY2025 · Dec 31, 2025Other Short-term Investments
55.89MUSDFY2025 · Dec 31, 2025Accounts Receivable
7.95MUSDFY2025 · Dec 31, 2025Inventory
30.16MUSDFY2025 · Dec 31, 2025Accounts Payable
1.49MUSDFY2025 · Dec 31, 2025Short-term Debt
7.24MUSDFY2025 · Dec 31, 2025Deferred Revenue
195.00KUSDFY2025 · Dec 31, 2025Long-term Debt
10.66MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
171.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
48.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-339.70MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
371.89MUSDvs all stocks (USD)
52-Week Low
17.86USDUpdated Sep 27, 202652-Week High
38.89USDUpdated Sep 27, 202652-Week Change
56.97%vs all stocks
Beta
1.92xvs all stocks
50-Day MA
34.33USDUpdated Sep 27, 2026200-Day MA
26.08USDUpdated Sep 27, 2026Avg 10-Day Volume
874.44KSharesUpdated Sep 27, 2026Avg 30-Day Volume
846.07KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
1.00USDUpdated Sep 27, 2026Other Income / Expense
1.81MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Is this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 54.3%, higher than 95% of its Medical Instruments & Supplies peers (median 8.3%)Significant
Profit margin: 0.54Industry median: 0.08Industry P95: 0.33Peers compared: 38.00
Current ratio is 9.69×, higher than 95% of its Medical Instruments & Supplies peers (median 2.67×)Significant
Current ratio: 9.69Industry median: 2.67Industry P95: 6.94Peers compared: 38.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 49,210,000Operating Cash Flow (USD, TTM): 16,877,000
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.88B, above the global median of $1.18BNotable
Market cap (USD): 1,883,059,087Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Boyun New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhuzhou Huarui Precision Company Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Svg Optronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Surgery Partners Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Infovision Optoelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangyin Jianghua Microelectronics Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiamei Food Packaging Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wintech-Nano Suzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ningbo Yunsheng (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Azad Engineering Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Flytech Technology Co., Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationCash-Flow Ratios Elevated
Jiangsu Wuyang Automation Co., Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationCash-Flow Ratios Elevated
Great Eastern Shipping Company Ltd.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityLow-Leverage Liquidity ConfigurationCash-Flow Ratios Elevated